Story 1
AI / ML
AI research assistants start to look like real lab tools
Two Nature papers pushed the idea of the AI scientist from marketing phrase toward something more operational. Google DeepMind's Co-Scientist generated and refined hypotheses that led to experimentally validated acute myeloid leukemia drug-repurposing candidates, while Robin went further in experimental biology by proposing dry age-related macular degeneration treatments, interpreting follow-up RNA-seq data, and identifying ABCA1 as a possible mechanistic lead. The important shift is not that AI has replaced researchers, but that it is beginning to contribute inside the iterative loop of hypothesis, experiment, and revision.